Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Lasers can help reduce skin side effects from cancer treatment.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Gefitinib can cause hair loss without scarring.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Gefitinib can cause scalp skin issues and permanent hair loss.

Eclipta alba extract shows potential as an anticancer agent by inhibiting cancer cell growth and promoting cell death.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Erlotinib can cause hair loss and texture changes.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Some chemotherapy can cause permanent hair loss.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.